TY - JOUR T1 - Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees JF - bioRxiv DO - 10.1101/2021.04.23.441101 SP - 2021.04.23.441101 AU - Pragya D. Yadav AU - Gajanan N. Sapkal AU - Priya Abraham AU - Raches Ella AU - Gururaj Deshpande AU - Deepak Y. Patil AU - Dimpal A Nyayanit AU - Nivedita Gupta AU - Rima R. Sahay AU - Anita M Shete AU - Samiran Panda AU - Balram Bhargava AU - V. Krishna Mohan Y1 - 2021/01/01 UR - http://biorxiv.org/content/early/2021/04/23/2021.04.23.441101.abstract N2 - The drastic rise in the number of cases in Maharashtra, India has created a matter of concern for public health experts. Twelve isolates of VUI lineage B.1.617 were propagated in VeroCCL81 cells and characterized. Convalescent sera of the COVID-19 cases and recipients of BBV152 (Covaxin) were able to neutralize VUI B.1.617.Competing Interest StatementThe authors have declared no competing interest. ER -